Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01669798
Title BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors AA Secord
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Duke Cancer Institute Durham North Carolina 27710 United States Details
University of Virginia Charlottesville Virginia 22908 United States Details
Virginia Oncology Associates Norfolk Virginia 23502 United States Details
*Shaded cells indicate that there was no data available from for the field